The BD Nexiva™ closed IV catheter system, the first-of-its-kind
all-in-one closed system IV catheter, is designed to minimize the risk
of IV catheter failure.
The catheter's built-in stabilization platform minimizes
movement that can lead to catheter complications, restarts and
associated costs, and reduces dislodgement by 84%. The system also meets INS standards and CDC guidelines for catheter stabilization.
Longer dwell times
BD Vialon™ biomaterial enables longer dwell times,2‡ supporting the current Infusion Therapy Standards of Practice for clinically indicated site rotation.3
As an integrated system, the
BD Nexiva system needs fewer add-on devices, minimizing the number of
manipulations that may lead to touch contamination and accidental
In a 2014 clinical study, it was demonstrated that BD Nexiva
catheters had a low rate of phlebitis and a median dwell time of 144
hours for those in place for 24 hours or more.
6 The longer
dwell times of closed systems led to a cost reduction of approximately
$1M per year per 1,000 beds compared to open systems.
Minimized treatment delays and complications
The BD Nexiva system is power-injection compatible, minimizing the
need to exchange catheter or tubing. Single and dual ports and 18- to
22-G catheters are indicated for use in computed tomography (CT) power
injection. Furthermore, the integrated system prevents leaking at the
catheter-extension set connection.